Super-resolution imaging compositions and methods using same
The invention provides compositions that may be used for imaging intracellular structures. The invention further provides methods of imaging intracellular structures. In certain embodiments, the compositions of the invention include trans-cyclooctene-containing ceramide lipids and tetrazine-containing rhodamine-related dyes.
1. A trans-cyclooctene-containing lipid, or a salt, solvate, stereoisomer, or any mixtures thereof, wherein the lipid comprises TCO-LINK-LIPID, wherein TCO is a trans-cyclooctene group, LINK is a bivalent linker, and wherein LIPID comprises at least one selected from the group consisting of a sphingolipid, phospholipid, sterol lipid and fatty acid
wherein LINK comprises:
—X(CR′R″) n C(═O)—, wherein
X is covalently conjugated to TCO and is selected from the group consisting of a covalent bond, —C(═O)—, —C(═O)O— and —C(═O)NR′—;
each occurrence of R′ and R″ is independently selected from the group consisting of H and optionally substituted C 1 -C 6 alkyl; and
n is an integer ranging from 1 to 20.
2. The trans-cyclooctene-containing lipid of claim 1 , wherein TCO is selected from the group consisting of:
wherein R′ is H or optionally substituted C 1 -C 6 alkyl, and wherein the heteroatom is not attached to the ring double bond.
3. The trans-cyclooctene-containing lipid of claim 2 , wherein TCO is selected from the group consisting of:
wherein R′ is H or optionally substituted C 1 -C 6 alkyl.
4. The trans-cyclooctene-containing lipid of claim 1 , wherein LIPID comprises at least one selected from the group consisting of sphingosine, 1-phosphocholine-sphingosine, 1-phosphoethanolamine-sphingosine, and a 1-glycosyl-sphingosine.
5. The trans-cyclooctene-containing lipid of claim 4 , wherein LIPID comprises sphingosine.
6. The trans-cyclooctene-containing lipid of claim 5 , wherein LIPID comprises sphingosine and is covalently conjugated to LINK through the 2-amino group of sphingosine.
7. The trans-cyclooctene-containing lipid of claim 1 , wherein n is 5.
8. The trans-cyclooctene-containing lipid of claim 1 , which is Cer-TCO or a salt, solvate, stereoisomer, or any mixtures thereof: